Article PDF
Avoid common mistakes on your manuscript.
References
Yuki N, Hartung H. Guillain-Barré syndrome. N Engl J Med. 2012;366:2294–2304.
Aral YZ, Gursel T, Ozturk G, Serdaroglu A. Guillain-Barre’ syndrome in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2001;18:343–346.
Brigo F, Balter R, Marradi P, Ferlisi M, Zaccaron A, Fiaschi A, et al. Vincristine-related neuropathy versus acute inflammatory demyelinating polyradiculoneuropathy in children with acute lymphoblastic leukemia. J Child Neurol. 2012;27:867–874.
Bahl A, Chakrabarty B, Gulati S, Vykunta Raju KN, Raja A, Bakhshi S. Acute onset flaccid quadriparesis in pediatric non-Hodgkin lymphoma: vincristine induced or Guillain-Barr’e syndrome? Pediatr Blood Cancer. 2010;55:1234–1235.
McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol. 1993;33:333–342.
Norman M, Elinder G, Finkel Y. Vincristine neuropathy and a Guillain Barre syndrome: a case with acute lymphatic leukemia and quadriparesis. Eur J Haematol. 1987;39:75–76.
Horino S, Rikiishi T, Niizuma H, Abe H, Watanabe Y, Onuma M, et al. Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia. Int J Hematol. 2009;90:483–485.
Teachey DT, Felix CA. Development of cold agglutinin autoimmune hemolytic anemia during treatment for pediatric acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2005; 27:397–399.
Pal PK. Clinical and electrophysiological studies in vincristine induced neuropathy. Electromyogr Clin Neurophysiol. 1999;39:323–330.
Guiheneuc P, Ginet J, Groleau JY, Rojouan J. Early phase of vincristine neuropathy in man. Electrophysiological evidence for a dying-back phenomenon, with transitory enhancement of spinal transmission of the monosynaptic reflex. J Neurol Sci. 1980;45:355–366.
References
Jha V, Murthy MS, Kohli S, Sud K, Gupta KL, Joshi K, et al. Secondary membranoproliferative glomerulonephritis due to hemolytic uremic syndrome: an unsual presentation Ren Fail. 1998;20:6:845–850.
Siegler RL, Brewer ED, Pysher TJ. Hemolytic uremic syndrome associated with glomerular disease Am J Kidney Dis. 1989;13:2:144–147.
Noris M, Remuzzi G. Hemolytic Uremic Syndrome. J Am Soc Nephrol. 2005;16:1035–1050.
Zipfel PF, Wolf G, John U, Kentouche K, Skerka C. Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura Pediatr Nephrol. 2011;26:1947–1956.
Zipfel PF, Skerka C. Complement regulators and inhibitors. Nat Rev Immunol. 2009;9:729–740.
Skerka C, Zipfel PF. Complement factor H related proteins in immune diseases Vaccine. 2008;30:19–24.
Servais A, Fremeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet. 2007;44:193–199.
Radhakrishnan S, Lunn A, Kirschfink M, Thorner P, Hebert D, Langlois V, et al. Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med. 2012;366:1165–1166.
References
Cargile CB, Goh DL, Goodman BK, Chen XN, Korenberg JR, Semenza GL, et al. Molecular cytogenetic characterization of a subtle interstitial del(3)(p25.3p26.2) in a patient with deletion 3p syndrome. Am J Med Genet. 2002;109:133–138.
Verjaal M, De Nef J. A patient with a partial deletion of the short arm of chromosome 3: karyotype: 46, XY, del(3) (p25). Am J Dis Child. 1978;132:43–45.
Cuoco C, Ronchetto P, Gimelli S, Béna F, Divizia MT, Lerone M, et al. Microarray based analysis of an inherited terminal 3p26.3 deletion, containing only the CHL1 gene, from a normal father to his two affected children. Orphanet J Rare Diseases. 2011;6:12.
Kaur A, Mahajan S, Singh JR. Cytogenetic profile of individuals with mental retardation. Int J Hum Genet. 2003;3:13–16.
Shuib S, McMullan D, Rattenberry E, Barber RM, Rahman F, Zatyka M, et al. Microarray based analysis of 3p25–p26 deletions (3p” syndrome), Am J Med Genet. Part A. 2009;149:2099–2105.
Fernandez T, Morgan T, Davis N, Klin A, Morris A, Farhi A, et al. Disruption of Contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome state Am J Hum Genet. 2004;74:1286–1293.
Malmgren H, Sahlen S, Wide K, Lundvall M, Blennow E. Distal 3p deletion syndrome: detailed molecular cytogenetic and clinical characterization of three small distal deletions and review. Am J Med Genet. 2007;143A:2143–2149.
Gunnarsson C, Foyn BC. Molecular characterization and clinical features of a patient with an interstitial deletion of 3p25.3–p26.1. Am J Med Genet. 2010;152 A:3110–3114.
McCullough BJ, Adams JC, Shilling DJ, Feeney MP, Sie KCY, Tempel BL. 3p″ syndrome defines a hearing loss locus in 3p25.3. Hearing Research. 2007;224:1–2:51–60.
Carayol J, Sacco R, Tores F, Rousseau F, Lewin P, Hager J, et al. Converging evidence for an association of ATP2B2 allelic variants with autism in male subjects. Biological Psychiatry. 2011;170:880–807.
References
Ferguson MK, Little AG, Skinner DB. Current concepts in the management of postoperative chylothorax. Ann Thorac Surg. 1985;40:542–545.
Bond SJ, Guzzetta PC, Snyder ML, Randolph JG. Management of pediatric postoperative chylothorax. Ann Thorac Surg. 1993;56:469–473.
Valentine VG, Raffin TA. The management of chylothorax. Chest. 1992;102:586–591.
Au M, Weber T, Fleming R. Successful use of somatostatin in a case of neonatal chylothorax. J Pediatr Surg. 2003;38:1106–1107.
Demos N, Kozel J, Screbo J. Somatostatin in the treatment of chylothorax. Chest. 2001;119:964–966.
Achildi O, Smith BP, Grewal H. Thoracoscopic ligation of the thoracic duct in a child with spontaneous chylothorax.. J Laparoendosc Adv Surg Tech A. 2006;16:546–549.
Soto-Martinez ME, Clifford V, Clarnette T, Ranganathan S, Massie RJ. Spontaneous chylothorax in a 2-year-old child. Med J Aust. 2009;190:262–264.
Janssen JP, Joosten HJ, Postmus PE. Thoracoscopic treatment of postoperative chylothorax after coronary bypass surgery. Thorax. 1994;49:1273.
Zoetmulder F, Rutgers E, Baas P. Thoracoscopic ligation of a thoracic duct leakage. Chest. 1994;106:1233–1234.
References
Kumar A, Gupta D, Sharath BN, Singh V, Sethi GR, Prasad J. Updated National Guidelines for Pediatric Tuberculosis in India, 2012. Indian Pediatr. 2013;50:301–306.
Sanklecha M, Raghavan K, Mehta M. Is INH alone enough for prophylaxis? Indian Pediatr. 1995;32:105.
References
Sinha DN, Reddy KS, Rahman K, Warren CW, Jones NR, Asma S. Linking Global Youth Tobacco Survey (GYTS) data to the WHO framework convention on tobacco control: The case for India. Indian J Public Health. 2006;50:76–89.
Bansal RK, Banerjee S. Substance use in child labourers. Indian J Psychiatry. 1993;35:159–161.
Jena R, Shukla TR, Hemraj P. Drug abuse in a rural community in Bihar: Some psychosocial correlates. Indian J Psychiatry. 1996;38:43–46.
Narain R, Satyanarayana L. Tobacco use among school students in India: the need for behavioral change. Indian Pediatr. 2005;42:732–733.
Murthy P, Manjunatha N, Subodh BN, Chand PK, Benegal V. Substance use and addiction research in India. Indian J Psychiatry. 2010;52:189–199.
References
Kumar A, Gupta D, Sharath BN, Singh V, Sethi GR, Prasad J. Updated National Guidelines for Pediatric Tuberculosis in India, 2012. Indian Pediatr. 2013;50:301–306.
World Health Organization. Dosing instructions for the use of currently available fixed-dose combination TB medicines for children, 2009. Available from: http://www.who.int/tb/challenges/interim_paediatric_fdc_dosing_instructions_sept09.pdf.
World Health Organization. Rapid Advice 2010: Treatment of tuberculosis in children. Available from: http://apps.who.int/iris/bitstream/10665/44444/1/9789241500449_eng.pdf.
Prasad K, Sahu JK. Duration of anti-tubercular treatment in tuberculous meningitis: challenges and opportunity. Neurol India. 2010;58:723–726.
Reference
Snider DE Jr. Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second East Africal/British Medical Research Council Study. Am Rev Respir Dis. 1976;114:471–475.
Wallace F. The chemotherapy of pulmonary tuberculosis: a review. Chest. 1979;76:785–796.
References
Kumar A, Gupta D, Sharath BN, Singh V, Sethi GR, Prasad J. Updated National Guidelines for Pediatric Tuberculosis in India, 2012. Indian Pediatr. 2013;50:301–306.
Lee HS, Park KU, Park JO, Chang HE, Song J, Choe G. Rapid, sensitive, and specific detection of Mycobacterium tuberculosis complex by real-time PCR on paraffinembedded human tissues. J Mol Diagn. 2011;13:390–394.
Peter JG, van Zyl-Smit RN, Denkinger CM, Pai M. Diagnosis of TB: State of the art. European Respiratory Monograph. 2012:58:124–143.
Boehme CC, Saacks S, O’Brien RJ. The changing landscape of diagnostic services for tuberculosis. Semin Res Crit Care Med. 2013;34:17–31.
Cantwell MF, Sehab ZM, Costello AM, et al. Brief report: congenital tuberculosis. New Engl J Med. 1994;330:1051–1054.
References
Kumar A, Gupta D, Sharath BN, Singh V, Sethi GR, Prasad J. Updated national guidelines for pediatric tuberculosis in India, 2012 Indian Pediatr. 2013;50:301–306.
Rapid advice: Treatment of TB in children. WHO 2010.
Thee S, Seddon JA, Donald PR, Seifart HI, Werely CJ, Hesseling AC, et al. Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations. Antimicrob Agents Chemother. 2011;55:5560–5567.
Menzies Dick, Al Jahdali H, Al Otaibi B. Recent developments in treatment of latent tuberculosis infection Indian J Med Res. 2011;133:257–266.
Reference
Kumar A, Gupta D, Sharath BN, Singh V, Sethi GR, Prasad J. Updated guidelines for pediatric tuberculosis in India 2012. Indian Pediatr. 2013;50:302.
References
Kumar A, Gupta D, Sharath BN, Singh V, Sethi GR, Prasad J. Updated National Guidelines for pediatric tuberculosis in India, 2012. Indian Pediatr. 2013;50:301–313.
Kim WS, Moon WK, Kim IO, Lee HJ, Im JG, Yeon KM, et al. Pulmonary tuberculosis in children: evaluation with CT. Am J Roentgenol. 1997;168:1005–1009.
Peng SS, Chan PC, Chang YC, Shih TT. Computed tomography of childrenwith pulmonary Mycobacterium tuberculosis infection. J Formos Med Assoc. 2011;110:744–749.
Swaminathan S, Raghavan A, Datta M, Paramasivan CN, Saravanan KC. Computerized tomography detects pulmonary lesions in children with normal radiographs diagnosed to havetuberculosis. Indian Pediatr. 2005;42:258–261.
References
Andronikou S, Brauer B, Galpin J, Brachmeyer S, Lucas S, Joseph E, et al. Interobserver variability in the detection of mediastinal and hilar lymph nodes on CT in children with suspected pulmonary tuberculosis. Pediatr Radiol. 2005;35:425–428.
de Jong PA, Nievelstein RJ. Normal mediastinal and hilar lymph nodes in children on multi-detector row chest computed tomography. Eur Radiol. 2012;22:318–321.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Rajeswari, B., Krishnan, S., Sarada, C. et al. Case reports and Correspondence. Indian Pediatr 50, 791–804 (2013). https://doi.org/10.1007/s13312-013-0201-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-013-0201-2